De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials

European Journal of Cancer

Volumn 50, Issue 15, 2014, Pages 2636-2648

  Masterson, Liam ^a,e   Moualed, Daniel ^b   Liu, Zi Wei ^c   Howard, James E F ^d   Dwivedi, Raghav C ^a   Tysome, James R ^a   Benson, Richard ^e   Sterling, Jane C ^f   Sudhoff, Holger ^g   Jani, Piyush ^a   Goon, Peter K C ^f  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b MILTON KEYNES UNIVERSITY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g Bielefeld Academic Teaching Hospital   (Germany)

Author keywords

De escalation of treatments; Human papillomavirus; Oropharyngeal carcinoma

Indexed keywords

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; COMPLICATION; DRUG EFFECTS; HUMAN; META ANALYSIS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CLINICAL PROTOCOLS; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84907429580     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.07.001     Document Type: Review

References (44)

1. C. de Martel, F. Ferlay, and S. Franceschi Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
2. I. Soerjomataram, J. Lortet-Tieulent, and D.M. Parkin Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions Lancet Oncol 380 2012 1840 1850
3. M.L. Gillison Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity Semin Oncol 31 2004 744 754
4. H.H. Sudhoff, H.P. Schwarze, D. Winder, L. Steinstraesser, M. Gormer, and M. Stanley Evidence for a causal association for HPV in head and neck cancers Eur Arch Otorhinolaryngol 268 2011 1541 1547
5. H. Mehanna, T. Beech, and T. Nicholson The prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region Head Neck 35 2012 747 755
6. H. Mehanna Oropharyngeal cancer N. Roland, V. Paleri, K. MacKenzie, P. Clarke, J. Homer, P. Pracy, Head and neck cancer 2011 British Association of Otorhinolaryngology, Head and Neck Surgery London 137 146
7. M.K. Lee, R.P. Nalliah, and M.K. Kim Prevalence and impact of complications on outcomes in patients hospitalized for oral and oropharyngeal cancer treatment Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112 2011 581 591
8. M.L. Gillison, T. Broutian, and R.K. Pickard Prevalence of oral HPV infection in the United States, 2009-2010 JAMA 307 2012 693 703
9. K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
10. A.G. Schache, T. Liloglou, J.M. Risk, A. Filia, T.M. Jones, and J. Sheard Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination Clin Cancer Res 17 2011 6262 6271
11. W.H. Westra The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer Head Neck Pathol 3 2009 78 81
12. J.F. Ensley, J.R. Jacobs, and A. Weaver Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck Clin Cancer Res 54 1984 811 814
13. B.H. Haughey, M.L. Hinni, and J.R. Salassa Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study Head Neck 33 2011 1683 1694
14. J.A. Bonner, P.M. Harari, J. Giralt, R.B. Cohen, C.U. Jones, and R.K. Sur Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
15. K.K. Ang, and Q.E. Zhang A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas J Clin Oncol 29 2011 5500
16. L. Koutcher, E. Sherman, and M. Fury Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head and neck cancer Int J Radiat Oncol Biol Phys 81 2011 915 922
17. J.B. Vermorken, J. Stöhlmacher-Williams, and I. Davidenko Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial Lancet Oncol 14 2013 697 710
18. J.P. Pignon, A. Maître, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients Radiother Oncol 92 2009 4 14
19. B. Kumar, K.G. Cordell, and J.S. Lee EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 128 137
20. A. Hong, T. Dobbins, and C.S. Lee Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer Eur J Cancer 46 2010 2088 2096
21. D.N. Hayes, J.R. Grandis, and A.K. El-Naggar The Cancer Genome Atlas integrated analysis of genome alterations in squamous cell carcinoma of the head and neck Proc Am Soc Clin Oncol 31 Suppl. 2013 abstr 6009
22. -Oncotarget 4 2013 1388 1398
23. A. Eisbruch, M. Schwartz, and C. Rasch Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60 2004 1425 1439
24. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures Radiat Oncol Biol Phys 68 2007 1289 1298
25. P.C. Levendag, D.N. Teguh, and P. Voet Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship Radiother Oncol 85 2007 64 73
26. B. O'Sullivan, and S.H. Huang Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation Radiother Oncol 103 2012 49 56
27. R.R. Laborde, V.W. Wang, and T.M. Smith Transcriptional profiling by sequencing of oropharyngeal cancer Mayo Clin Proc 87 2012 226 232
28. M.J. Ward, S.M. Thirdborough, and T. Mellows Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer Br J Cancer 110 2014 489 500
29. E.M. Genden, T. Kotz, and C.C. Tong Transoral robotic resection and reconstruction for head and neck cancer Laryngoscope 121 2011 1668 1674
30. S. Huang, and B. O'Sullivan Temporal regression of cervical lymph node in N2-N3 head-and-neck cancer treated with primary radiation therapy +/- chemotherapy: stratified by HPV status Int J Radiat Oncol Biol Phys 1 2012 S205
31. P.K. Pellitteri, K.T. Robbins, and T. Neuman Expanded application of selective neck dissection with regard to nodal status Head Neck 19 1997 260 265
32. R.J. Slebos, Y. Yi, and K. Ely Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma Clin Cancer Res 12 2006 701 709
33. J.M. Spangle, and K. Munger The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species PLoS Pathog 9 2013 e1003237
34. J.B. Vermorken, A. Psyrri, and R. Mesia Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial Ann Oncol 25 2014 801 807
35. S. Lyford-Pike, S. Peng, and G.D. Young Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma Clin Cancer Res 73 2013 1733 1741
36. Study of MK-3475 in participants with advanced solid tumors (MK-3475-012/KEYNOTE-012). ClinicalTrials.gov; 2013.
37. V.W. Lui, M.L. Hedberg, and H. Li Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers Cancer Discov 3 2013 761 769
38. S.I. Chiosea, J.R. Grandis, and V.W. Lui PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma BMC Cancer 13 2013 602
39. Jones T. A phase I, dose escalation trial of recombinant listeria monocytogenes (Lm)-based vaccine encoding human papilloma virus serotype 16 target antigens (ADXS11-001) in patients with HPV-16 +ve oropharyngeal carcinoma. Available at: http://www.lctu.org.uk/trial/trial-info.asp?id=73&tgcode=2&menuid=30.
40. B. Klingenberg, H.C. Hafkamp, and A. Haesevoets P16 INK4A overexpression is frequently detected in tumour-free tonsil tissue without association with HPV Histopathology 56 2010 957 967
41. National Institutes of Health NCI Cancer Therapy Evaluation Program. Common terminology criteria for adverse events 2009 US Department of Health and Human Services
42. D. Rischin, and R.J. Young Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial J Clin Oncol 28 2010 4142 4148
43. M.R. Posner, J.H. Lorch, and O. Goloubeva Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial Ann Oncol 22 2011 1071 1077
44. M.L. Gillison, Q. Zhang, and R. Jordan Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer J Clin Oncol 10 2012 2102 2111